Ovarian cancer – Life with Disease

Go back

Ovarian cancer is a serious disease that often develops silently, making it challenging to detect in its early stages. Understanding what to expect during and after treatment, how the disease may progress, and where to find support can help patients and families navigate this difficult journey with greater confidence and hope.

Understanding Prognosis and Survival

Learning about the expected outcome after an ovarian cancer diagnosis is deeply personal, and not everyone wants detailed information right away. It’s completely normal to feel overwhelmed by the possibilities and uncertain about the future. Your specialist doctor can provide the most accurate picture based on your specific situation, including the stage and type of cancer, your overall health, and how well treatments are working for you.[1][16]

Ovarian cancer survival depends on many factors. When cancer is caught early and hasn’t spread beyond the ovaries, treatment outcomes tend to be more favorable. Unfortunately, roughly only 20 percent of ovarian cancers are detected before spreading to other areas, which makes early detection particularly challenging.[14] Advanced cancer—meaning the disease has moved outside the ovary to the pelvis, abdomen, or distant organs like the lungs or liver—presents greater treatment challenges. However, it’s important to know that even advanced cancer can sometimes be controlled for extended periods, allowing patients to maintain quality of life for months or even years.[3][16]

The stage of your cancer at diagnosis significantly influences your outlook. Staging describes how far the cancer has spread, while grading indicates how abnormal the cancer cells look under a microscope. High-grade tumors, such as high-grade serous adenocarcinoma—the most common subtype—tend to grow more aggressively than low-grade tumors.[2][5] Your treatment history also matters. If you’ve already undergone surgery and chemotherapy, your doctor will consider what treatments you’ve received and how well they worked when discussing what comes next.[16]

Many patients wonder about timeframes. While doctors cannot predict exactly how long someone will live, they may be able to provide estimates based on their experience treating similar cases. These estimates consider not just the cancer itself but also your fitness level, age, ability to tolerate treatment, and whether the cancer is newly diagnosed or has returned after previous treatment.[16] For some women, treatment can control the disease and relieve symptoms for many months and sometimes years. For others facing more advanced disease or who cannot tolerate further treatment, the timeline may be shorter.[16]

⚠️ Important
If you feel ready to discuss your prognosis with your healthcare team, don’t hesitate to ask. Your doctors and nurses understand that this information can be difficult to hear, and they are prepared to support you through these conversations. You can also choose to wait until you feel more prepared—there is no right or wrong way to approach these discussions.

How Ovarian Cancer Progresses Without Treatment

When ovarian cancer develops, abnormal cells in the ovaries, fallopian tubes, or the tissue lining the abdomen (called the peritoneum) begin to grow and divide uncontrollably. Over time, these cells form a tumor. If left untreated, the cancer continues to grow and can invade nearby tissues and organs.[1][5]

Ovarian cancer often spreads in a specific pattern. Because the ovaries sit within the pelvis near other reproductive organs and the abdominal cavity, cancer cells can easily shed from the ovary and float through the fluid inside the abdomen. This allows them to land on and invade other structures such as the bladder, bowel, stomach, and the tissue covering abdominal organs. The cancer may also spread through the lymphatic system to nearby lymph nodes, or more rarely, through the bloodstream to distant sites like the liver, lungs, or chest.[3][9]

One of the most troubling aspects of ovarian cancer is that it can develop and spread throughout the abdomen before causing noticeable symptoms. This silent progression means the disease is often quite advanced by the time a woman seeks medical attention.[3] Early-stage ovarian cancer might not produce any symptoms at all, which is why it’s frequently described as a “silent killer.” When symptoms do appear, they are often vague and can be mistaken for common digestive problems such as bloating, gas, or constipation.[14]

As the cancer advances without treatment, symptoms typically become more pronounced. Women may experience persistent abdominal bloating or swelling, ongoing pelvic or abdominal discomfort, difficulty eating or feeling full quickly, unexplained weight loss, extreme fatigue, back pain, and changes in bathroom habits including constipation or a frequent urgent need to urinate.[1][7] Some may also notice vaginal discharge or abnormal bleeding, particularly if bleeding occurs outside the normal menstrual cycle or after menopause.[3]

Without intervention, the growing cancer burden eventually affects multiple organ systems and body functions. The cancer can press on or invade the intestines, potentially leading to bowel obstructions that prevent normal digestion and elimination. Fluid may accumulate in the abdomen, a condition called ascites, causing significant discomfort and swelling. Cancer affecting the lungs or chest cavity can lead to fluid buildup around the lungs, making breathing difficult. These progressive complications significantly impact quality of life and overall survival.[3][6]

Possible Complications of Ovarian Cancer

Even with treatment, ovarian cancer and its therapies can lead to various complications that affect different parts of the body. Understanding these potential issues helps patients recognize warning signs early and seek appropriate medical care.[18]

One of the most common and serious complications involves the bowel. Because ovarian cancer often sits on the outside of the intestines or spreads to nearby abdominal structures, digestive problems are frequent. Some patients experience ongoing constipation or diarrhea. The most concerning bowel complication is obstruction, which occurs when cancer growth prevents the normal passage of food and waste through the intestines. Signs of bowel obstruction include severe constipation, nausea, vomiting, and abdominal pain. This is a medical emergency requiring immediate attention.[18][23]

Cancer and its treatment can also affect the urinary system. Bladder function may be disrupted, causing frequent urination, urgency, or difficulty fully emptying the bladder. Some women find these symptoms persist long after treatment ends, taking up to a year to normalize in some cases.[18][23]

Chemotherapy, a cornerstone of ovarian cancer treatment, comes with its own set of potential complications. Peripheral neuropathy—numbness, tingling, or pain in the fingers and toes—is common and can sometimes become permanent even after chemotherapy ends. Patients may also experience muscle and joint aches, weak legs, nausea, vomiting, extreme fatigue, and loss of appetite.[18] A phenomenon known as “chemo brain” describes the thinking and memory problems some patients notice during and after chemotherapy. This mental fog can affect concentration, word-finding, and short-term memory.[18]

Recurrence is unfortunately a common complication of ovarian cancer. More than 80 percent of patients with advanced ovarian cancer experience disease recurrence, meaning the cancer returns after a period of remission.[14][20] Recurrent cancer may appear in the same location as the original tumor or in different areas of the body. Symptoms of recurrence can mirror those of the initial diagnosis: abdominal pain or swelling, changes in bowel movements, fatigue, elevated CA-125 blood marker levels, pelvic and lower back pain, or urinary issues.[20]

Surgery for ovarian cancer typically involves removing one or both ovaries and often the uterus. For women who haven’t yet gone through menopause naturally, this triggers what’s called surgical menopause. This sudden loss of hormone production can cause hot flashes, night sweats, mood changes, vaginal dryness, and increased risk of bone loss (osteoporosis). These symptoms can be more intense than natural menopause because they happen abruptly rather than gradually.[17][19]

For younger women hoping to have children in the future, ovarian cancer and its treatment can affect fertility. Depending on the extent of surgery and whether chemotherapy is needed, some women may lose the ability to become pregnant. This can be an emotionally devastating complication, and women should discuss fertility preservation options with their healthcare team before treatment begins if family planning is a concern.[17][19]

Impact on Daily Life

Living with ovarian cancer affects virtually every aspect of daily life, from physical capabilities to emotional well-being, relationships, work, and leisure activities. The disease and its treatment create challenges that require ongoing adjustment and support.[17][21]

Physical symptoms can significantly limit what you’re able to do each day. Fatigue is one of the most common and frustrating side effects. This isn’t ordinary tiredness that improves with rest—it’s a profound exhaustion that can make even simple tasks like showering or preparing a meal feel overwhelming. Many patients find it takes a full year to recover their typical energy levels after completing chemotherapy.[18] Planning activities around periods when you have the most energy and allowing yourself to rest without guilt becomes essential for managing daily routines.[21]

Changes in appetite and eating habits are common. Some women feel full after eating very little, while others lose their appetite entirely. Nausea, taste changes, and bowel problems can all interfere with the enjoyment and routine of meals. Working with a dietician to create a balanced eating plan tailored to your specific challenges can help ensure you’re getting adequate nutrition even when eating feels difficult.[21][23]

Body image and sexuality often suffer. Surgical scars, hair loss from chemotherapy, weight changes, and the physical effects of surgical menopause can all impact how you feel about your appearance. The loss of ovaries and potentially the uterus may affect your sense of femininity and sexual identity. Vaginal dryness, pain during intercourse, and decreased libido are common physical changes that can strain intimate relationships. Open communication with partners about these changes, along with patience and willingness to adapt, helps maintain connection during this challenging time.[17][19]

The emotional impact can be just as challenging as physical symptoms. Feelings of fear, anxiety, sadness, anger, frustration, and grief are all normal responses to a cancer diagnosis. Many patients worry constantly about recurrence, find it difficult to plan for the future, or struggle with uncertainty. Some days may bring overwhelming emotions, while others feel more manageable. Allowing yourself to feel whatever arises without judgment is important. Professional counseling, support groups, or talking with trusted friends and family members can provide outlets for processing these emotions.[17][18][21]

Work life often requires significant adjustments. Treatment schedules, fatigue, and symptoms may make it impossible to maintain previous work hours or responsibilities. Some women need extended time off, while others can continue working with accommodations. Decisions about whether and when to tell colleagues about your diagnosis, how much detail to share, and what kind of support to request can feel complicated. Understanding your legal rights regarding medical leave and workplace accommodations is important for protecting both your health and employment.[17][23]

Social activities and hobbies may need to be modified or temporarily set aside. Fatigue, treatment schedules, and immune system concerns can limit your ability to participate in activities you once enjoyed. However, staying connected with others and finding joy in small ways contributes significantly to quality of life. Adapting activities to your current abilities—perhaps shorter visits with friends, gentler forms of exercise, or new hobbies that accommodate physical limitations—helps maintain a sense of normalcy and purpose.[21]

Financial stress is a reality for many cancer patients. Medical bills, time off work, travel to appointments, and prescription costs can create significant burden. Many women find themselves navigating complex insurance issues, applying for disability benefits, or seeking financial assistance programs. Social workers at cancer centers can help identify resources and support services to ease financial strain.[17][23]

⚠️ Important
Creating a “new normal” takes time and patience. What worked before your diagnosis may not work now, and that’s okay. Setting small, achievable goals each day or week can help you maintain a sense of control and accomplishment. Whether it’s taking a short walk, preparing one meal, or connecting with a friend, celebrate these victories. Building resilience means allowing yourself to honor difficult feelings, then gently working to get back into routines and stay present with hope.

Support for Families and Caregivers

When someone is diagnosed with ovarian cancer, the entire family is affected. Loved ones often feel helpless, scared, and uncertain about how best to provide support. Understanding what your family member is facing and how you can help makes a meaningful difference in their cancer journey.[17][22]

Families should understand that ovarian cancer is a serious disease requiring complex treatment, typically involving surgery and chemotherapy. The treatment journey can be long, with intense periods followed by recovery time and ongoing monitoring for recurrence. Educating yourselves about the specific type and stage of cancer your loved one has, what treatments they’ll receive, and what side effects to expect helps everyone feel more prepared.[1][12]

Clinical trials represent an important option that families should understand. These research studies test new treatments or approaches to see if they are safe and effective. For some patients, especially those with recurrent disease or limited treatment options, participating in a clinical trial may provide access to promising new therapies not yet widely available. However, clinical trials also involve uncertainty—the new treatment may or may not work better than standard options, and there may be unknown side effects.[12][22]

Families can play a crucial role in helping patients explore whether clinical trials might be appropriate. This starts with open conversations with the oncology team about whether any relevant trials are available for the patient’s specific situation. Not all patients are eligible for every trial—factors like cancer type, stage, previous treatments, and overall health determine eligibility. The National Cancer Institute and other cancer organizations maintain databases where families can search for available ovarian cancer clinical trials.[12][22]

If a clinical trial seems like a possibility, family members can help by asking important questions: What is the purpose of this trial? What does the experimental treatment involve? What are the potential benefits and risks? How does it compare to standard treatment? What additional time commitment is required? Will insurance cover the costs? Having extra sets of ears during these discussions is valuable because patients may feel overwhelmed and miss important details.[22]

Practical support is often the most helpful thing families can provide. This might include driving to appointments, helping manage medications, preparing meals, assisting with household tasks, or researching treatment options and support resources. Many patients find the administrative burden of cancer care—scheduling appointments, dealing with insurance, organizing medical records—to be exhausting. Families can lighten this load by taking on coordination tasks.[17][22]

Emotional support matters tremendously but can be challenging to provide. Sometimes loved ones want to maintain positivity and avoid difficult conversations, but patients often need space to express fear, sadness, and anger without feeling they must protect others’ feelings. The most helpful approach is often simply listening without trying to fix things or offering empty reassurances. Being present, acknowledging the difficulty of the situation, and validating emotions provides profound comfort.[17][21]

Caregivers also need support for themselves. Caring for someone with cancer is physically and emotionally demanding. Caregiver burnout is real and can affect your own health if you don’t take breaks and seek support. Many hospitals and cancer organizations offer support groups specifically for caregivers where you can share experiences and coping strategies with others facing similar challenges. Taking care of yourself isn’t selfish—it’s necessary to sustain your ability to care for your loved one.[17][22]

As treatment progresses, families may need to discuss difficult topics including advance care planning, end-of-life wishes, and what to do if the cancer cannot be controlled. While these conversations are painful, having them ensures that the patient’s values and preferences guide care decisions. Social workers, palliative care teams, and hospital chaplains can help families navigate these sensitive discussions.[17][23]

Connecting with ovarian cancer advocacy organizations and support groups can benefit the entire family. Organizations like the National Ovarian Cancer Coalition and others offer educational materials, peer support programs, financial assistance resources, and connections to others who understand what you’re going through. Online communities allow people to connect from home when travel or time constraints make in-person meetings difficult.[21][22]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Bevacizumab (Avastin®) – A monoclonal antibody that targets the VEGF/VEGFR pathway to inhibit tumor blood vessel growth; approved for patients with newly-diagnosed and relapsed ovarian cancer
  • Mirvetuximab soravtansine (Elahere™) – An antibody-drug conjugate that targets the folate receptor pathway and delivers toxic drugs to tumors; approved for subsets of patients with advanced ovarian cancer
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced ovarian cancer that has DNA mismatch repair deficiency (dMMR)
  • Pembrolizumab (Keytruda®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced ovarian cancer that has high microsatellite instability (MSI-H) or DNA mismatch repair deficiency (dMMR)

Ongoing Clinical Trials on Ovarian cancer

  • Study Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +6
  • Study of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

    Recruiting

    2 1 1 1
    Belgium France Germany Italy Poland Spain
  • Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

    Recruiting

    2 1 1
    Denmark France Italy Spain
  • Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Germany Romania Spain
  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Hungary +6
  • Title: Study of 5-Aminolevulinic Acid for detecting tumor tissue during surgery in patients with ovarian cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Germany
  • Study of Pembrolizumab with Etoposide and Cisplatin for First-Line Treatment in Patients with Small Cell Ovarian Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

    Recruiting

    3 1 1 1
    Portugal
  • Study on Olaparib and Bevacizumab for Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated drugs:
    Spain
  • Study on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment

    Recruiting

    3 1 1 1
    Czechia France Germany Italy

References

https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/symptoms-causes/syc-20375941

https://www.cdc.gov/ovarian-cancer/about/index.html

https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer

https://www.cancer.org/cancer/types/ovarian-cancer.html

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer

https://www.ncbi.nlm.nih.gov/books/NBK567760/

https://medlineplus.gov/ovariancancer.html

https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/diagnosis-treatment/drc-20375946

https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer

https://cancer.ca/en/cancer-information/cancer-types/ovarian/treatment

https://www.nhs.uk/conditions/ovarian-cancer/treatment/

https://www.cdc.gov/ovarian-cancer/treatment/index.html

https://www.aacr.org/blog/2025/09/18/shining-a-light-on-new-approaches-for-ovarian-cancer-treatment-and-detection/

https://www.cancerresearch.org/immunotherapy-by-cancer-type/ovarian-cancer

https://www.mdanderson.org/cancer-types/ovarian-cancer/ovarian-cancer-treatment.html

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/living-with/coping-if-your-cancer-cant-be-cured

https://ovarian.org.uk/ovarian-cancer/living-with-ovarian-cancer/

https://cancerblog.mayoclinic.org/2023/10/04/life-after-ovarian-cancer-coping-with-side-effects-fear-of-recurrence-and-finding-support/

https://www.ucsfhealth.org/education/taking-charge-living-with-ovarian-cancer

https://ourwayforward.com/ovarian-cancer/living-with-ovarian-cancer/

https://www.myovariancancerteam.com/resources/living-well-with-ovarian-cancer

https://ovarian.org/programs-and-resources/resources/

https://blog.virginiacancer.com/what-to-expect-after-completing-ovarian-cancer-treatment

FAQ

Can ovarian cancer come back after successful treatment?

Yes, unfortunately recurrence is common with ovarian cancer. More than 80 percent of patients with advanced ovarian cancer experience disease recurrence after initial treatment. This means the cancer returns either in the same area or elsewhere in the body. Regular monitoring with check-ups, blood tests, and imaging helps detect recurrence early so treatment can begin promptly.

Will I be able to have children after ovarian cancer treatment?

This depends on several factors including the extent of surgery required and whether you need chemotherapy. If both ovaries and the uterus must be removed, pregnancy will not be possible without assisted reproductive technologies like surrogacy. However, some younger women with early-stage disease may be able to preserve fertility through certain surgical approaches. It’s crucial to discuss fertility concerns with your healthcare team before treatment begins so all options can be explored.

Can I take hormone replacement therapy if I’ve had ovarian cancer?

This is a common myth—women who have had ovarian cancer can actually use hormone replacement therapy. The use of supplemental hormones does not affect whether the disease recurs. HRT can help manage symptoms of surgical menopause caused by removal of the ovaries and protect against bone loss, just as it does for women who haven’t had ovarian cancer.

How long does it take to recover from ovarian cancer treatment?

Recovery varies significantly from person to person, but it can take a full year to recover from chemotherapy and regain typical energy levels. Some side effects like peripheral neuropathy (numbness and tingling in fingers and toes) can be permanent. Bowel and bladder function may not normalize for up to a year after treatment. It’s important to be patient with yourself and recognize that healing takes time.

Should I consider genetic testing after an ovarian cancer diagnosis?

Yes, your doctor will likely recommend genetic testing. Testing can identify gene changes like BRCA1, BRCA2, or Lynch syndrome that increase ovarian cancer risk. Knowing you have an inherited genetic change is important for several reasons: it helps your doctor make treatment decisions, it may qualify you for certain targeted therapies, and it provides valuable information for your blood relatives who may share the same genetic changes and face similar risks.

🎯 Key Takeaways

  • Ovarian cancer often develops silently and spreads before causing symptoms, making only 20% of cases detectable in early stages when treatment is most effective.
  • More than 80% of patients with advanced ovarian cancer experience recurrence, making ongoing monitoring after treatment completion absolutely essential.
  • Complete recovery from chemotherapy can take a full year, and some side effects like numbness in fingers and toes may become permanent.
  • Despite common myths, women who’ve had ovarian cancer can safely use hormone replacement therapy to manage menopause symptoms without increasing recurrence risk.
  • Families play a crucial role in helping patients explore clinical trials, which may offer access to promising new treatments not yet widely available.
  • Bowel complications are common because ovarian cancer often affects the intestines, with obstruction being the most serious issue requiring emergency care.
  • Emotional impacts like fear of recurrence and uncertainty about the future can be just as challenging as physical symptoms, making mental health support essential.
  • Taking birth control pills actually reduces ovarian cancer risk, contradicting the misconception that hormonal contraceptives increase cancer danger.

Connected medications: